Characteristics and outcomes of 118,155 COVID-19 individuals with a history of cancer in the United States and Spain
Abstract Purpose We aimed to describe the demographics, cancer subtypes, comorbidities and outcomes of patients with a history of cancer with COVID-19 from March to June 2020. Secondly, we compared patients hospitalized with COVID-19 to patients diagnosed with COVID-19 and patients hospitalized with influenza.Methods We conducted a cohort study using eight routinely-collected healthcare databases from Spain and the US, standardized to the Observational Medical Outcome Partnership common data model. Three cohorts of patients with a history of cancer were included: i) diagnosed with COVID-19, ii) hospitalized with COVID-19, and iii) hospitalized with influenza in 2017-2018. Patients were followed from index date to 30 days or death. We reported demographics, cancer subtypes, comorbidities, and 30-day outcomes.Results We included 118,155 patients with a cancer history in the COVID-19 diagnosed and 41,939 in the COVID-19 hospitalized cohorts. The most frequent cancer subtypes were prostate and breast cancer (range: 5-19% and 1-14% in the diagnosed cohort, respectively). Hematological malignancies were also frequent, with non-Hodgkin’s lymphoma being among the 5 most common cancer subtypes in the diagnosed cohort. Overall, patients were more frequently aged above 65 years and had multiple comorbidities. Occurrence of death ranged from 8% to 14% and from 18% to 26% in the diagnosed and hospitalized COVID-19 cohorts, respectively. Patients hospitalized with influenza (n=242,960) had a similar distribution of cancer subtypes, sex, age and comorbidities but lower occurrence of adverse events.Conclusion Patients with a history of cancer and COVID-19 have advanced age, multiple comorbidities, and a high occurence of COVID-19-related events. Additionaly, hematological malignancies were frequent in these patients.This observational study provides epidemiologic characteristics that can inform clinical care and future etiological studies..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
bioRxiv.org - (2021) vom: 17. Jan. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| doi: |
10.1101/2021.01.12.21249672 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI019745222 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI019745222 | ||
| 003 | DE-627 | ||
| 005 | 20230429074821.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210118s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2021.01.12.21249672 |2 doi | |
| 035 | |a (DE-627)XBI019745222 | ||
| 035 | |a (DE-599)biorXiv10.1101/2021.01.12.21249672 | ||
| 035 | |a (biorXiv)10.1101/2021.01.12.21249672 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Roel, Elena |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Characteristics and outcomes of 118,155 COVID-19 individuals with a history of cancer in the United States and Spain |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Purpose We aimed to describe the demographics, cancer subtypes, comorbidities and outcomes of patients with a history of cancer with COVID-19 from March to June 2020. Secondly, we compared patients hospitalized with COVID-19 to patients diagnosed with COVID-19 and patients hospitalized with influenza.Methods We conducted a cohort study using eight routinely-collected healthcare databases from Spain and the US, standardized to the Observational Medical Outcome Partnership common data model. Three cohorts of patients with a history of cancer were included: i) diagnosed with COVID-19, ii) hospitalized with COVID-19, and iii) hospitalized with influenza in 2017-2018. Patients were followed from index date to 30 days or death. We reported demographics, cancer subtypes, comorbidities, and 30-day outcomes.Results We included 118,155 patients with a cancer history in the COVID-19 diagnosed and 41,939 in the COVID-19 hospitalized cohorts. The most frequent cancer subtypes were prostate and breast cancer (range: 5-19% and 1-14% in the diagnosed cohort, respectively). Hematological malignancies were also frequent, with non-Hodgkin’s lymphoma being among the 5 most common cancer subtypes in the diagnosed cohort. Overall, patients were more frequently aged above 65 years and had multiple comorbidities. Occurrence of death ranged from 8% to 14% and from 18% to 26% in the diagnosed and hospitalized COVID-19 cohorts, respectively. Patients hospitalized with influenza (n=242,960) had a similar distribution of cancer subtypes, sex, age and comorbidities but lower occurrence of adverse events.Conclusion Patients with a history of cancer and COVID-19 have advanced age, multiple comorbidities, and a high occurence of COVID-19-related events. Additionaly, hematological malignancies were frequent in these patients.This observational study provides epidemiologic characteristics that can inform clinical care and future etiological studies. | ||
| 700 | 1 | |a Pistillo, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Recalde, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a Sena, Anthony G. |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-Bertolín, Sergio |e verfasserin |4 aut | |
| 700 | 1 | |a Aragón, María |e verfasserin |4 aut | |
| 700 | 1 | |a Puente, Diana |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmed, Waheed-Ul-Rahman |e verfasserin |4 aut | |
| 700 | 1 | |a Alghoul, Heba |e verfasserin |4 aut | |
| 700 | 1 | |a Alser, Osaid |e verfasserin |4 aut | |
| 700 | 1 | |a Alshammari, Thamir M. |e verfasserin |4 aut | |
| 700 | 1 | |a Areia, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Blacketer, Clair |e verfasserin |4 aut | |
| 700 | 1 | |a Carter, William |e verfasserin |4 aut | |
| 700 | 1 | |a Casajust, Paula |e verfasserin |4 aut | |
| 700 | 1 | |a Culhane, Aedin C. |e verfasserin |4 aut | |
| 700 | 1 | |a Dawoud, Dalia |e verfasserin |4 aut | |
| 700 | 1 | |a DeFalco, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Duvall, Scott L. |e verfasserin |4 aut | |
| 700 | 1 | |a Falconer, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Golozar, Asieh |e verfasserin |4 aut | |
| 700 | 1 | |a Gong, Mengchun |e verfasserin |4 aut | |
| 700 | 1 | |a Hester, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Hripcsak, George |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Eng Hooi |e verfasserin |4 aut | |
| 700 | 1 | |a Jeon, Hokyun |e verfasserin |4 aut | |
| 700 | 1 | |a Jonnagaddala, Jitendra |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Lana Y.H. |e verfasserin |4 aut | |
| 700 | 1 | |a Lynch, Kristine E. |e verfasserin |4 aut | |
| 700 | 1 | |a Matheny, Michael E. |e verfasserin |4 aut | |
| 700 | 1 | |a Morales, Daniel R. |e verfasserin |4 aut | |
| 700 | 1 | |a Natarajan, Karthik |e verfasserin |4 aut | |
| 700 | 1 | |a Nyberg, Fredrik |e verfasserin |4 aut | |
| 700 | 1 | |a Ostropolets, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Posada, José D. |e verfasserin |4 aut | |
| 700 | 1 | |a Prats-Uribe, Albert |e verfasserin |4 aut | |
| 700 | 1 | |a Reich, Christian G. |e verfasserin |4 aut | |
| 700 | 1 | |a Rivera, Donna |e verfasserin |4 aut | |
| 700 | 1 | |a Schilling, Lisa M. |e verfasserin |4 aut | |
| 700 | 1 | |a Soerjomataram, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Karishma |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, Nigam |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Yang |e verfasserin |4 aut | |
| 700 | 1 | |a Spotniz, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Subbian, Vignesh |e verfasserin |4 aut | |
| 700 | 1 | |a Suchard, Marc A. |e verfasserin |4 aut | |
| 700 | 1 | |a Trama, Annalisa |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Lin |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Ryan, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Prieto-Alhambra, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Kostka, Kristin |e verfasserin |4 aut | |
| 700 | 1 | |a Duarte-Salles, Talita |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2021) vom: 17. Jan. |
| 773 | 1 | 8 | |g year:2021 |g day:17 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.01.12.21249672 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 17 |c 01 | ||
| 953 | |2 045F |a 570 | ||